ICN Hungary Ltd.

ICN Hungary is producing and marketing a wide range of preparations in different forms: Iminodibenzyl, 4,7-Dichloroquinoline, 3,4,5-Trimethoxybenzoic Acid Methyl Ester, Phenylmalonic Acid, Mexiletine, Buspirone, Phenobarbital and Phenobarbital.
ICN Hungary is the exclusive producer of morphine, morphine and codeine derivatives, and psychotropic compounds in Hungary, and one of the few companies in the world that deals with producing such substances. ICN Hungary supplies 10% of the world's morphine production intended for medical purposes, and 30% of Europe's morphine production.
ICN Hungary is a significant company in the field of producing active pharmaceutical ingredients and intermediates.

Activity:

- Manufacturing

Product / Technology type(s) covered:

- API / chemicals
- Generics
- NCE (new chemical entities)
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)

Therapeutic targets:

- Allergy
- Asthma
- Cancer
- Cardiovascular
- Central nervous system
- Dermatology
- Epidemiology
- Gastrointestinal
- Infectious Diseases
- Respiratory Medicine

Markets Covered

a. HeadQuarter: Hungary

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: 1960